nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.0187	0.0366	CcSEcCtD
Sevoflurane—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0157	0.0308	CcSEcCtD
Sevoflurane—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0126	0.0246	CcSEcCtD
Sevoflurane—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0114	0.0222	CcSEcCtD
Sevoflurane—Glycosuria—Furosemide—dilated cardiomyopathy	0.0107	0.021	CcSEcCtD
Sevoflurane—Renal failure—Spironolactone—dilated cardiomyopathy	0.0088	0.0172	CcSEcCtD
Sevoflurane—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00853	0.0167	CcSEcCtD
Sevoflurane—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00738	0.0144	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00723	0.0142	CcSEcCtD
Sevoflurane—Cough increased—Lisinopril—dilated cardiomyopathy	0.00713	0.014	CcSEcCtD
Sevoflurane—Oliguria—Lisinopril—dilated cardiomyopathy	0.00708	0.0139	CcSEcCtD
Sevoflurane—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00695	0.0136	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00653	0.0128	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00653	0.0128	CcSEcCtD
Sevoflurane—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00641	0.0126	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00634	0.0124	CcSEcCtD
Sevoflurane—Wheezing—Lisinopril—dilated cardiomyopathy	0.00634	0.0124	CcSEcCtD
Sevoflurane—Urinary retention—Furosemide—dilated cardiomyopathy	0.00601	0.0118	CcSEcCtD
Sevoflurane—Confusional state—Spironolactone—dilated cardiomyopathy	0.00575	0.0113	CcSEcCtD
Sevoflurane—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00572	0.0112	CcSEcCtD
Sevoflurane—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00571	0.0112	CcSEcCtD
Sevoflurane—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00559	0.0109	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00542	0.0106	CcSEcCtD
Sevoflurane—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00535	0.0105	CcSEcCtD
Sevoflurane—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00527	0.0103	CcSEcCtD
Sevoflurane—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00513	0.01	CcSEcCtD
Sevoflurane—Somnolence—Spironolactone—dilated cardiomyopathy	0.00507	0.00993	CcSEcCtD
Sevoflurane—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.005	0.00979	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00493	0.00964	CcSEcCtD
Sevoflurane—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00492	0.00964	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0049	0.00959	CcSEcCtD
Sevoflurane—Renal failure—Furosemide—dilated cardiomyopathy	0.00479	0.00937	CcSEcCtD
Sevoflurane—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0047	0.00921	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0046	0.00901	CcSEcCtD
Sevoflurane—Urticaria—Spironolactone—dilated cardiomyopathy	0.00453	0.00887	CcSEcCtD
Sevoflurane—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00451	0.00883	CcSEcCtD
Sevoflurane—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00451	0.00882	CcSEcCtD
Sevoflurane—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00432	0.00845	CcSEcCtD
Sevoflurane—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00428	0.00839	CcSEcCtD
Sevoflurane—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0042	0.00823	CcSEcCtD
Sevoflurane—Pruritus—Spironolactone—dilated cardiomyopathy	0.00404	0.0079	CcSEcCtD
Sevoflurane—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00403	0.00789	CcSEcCtD
Sevoflurane—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00402	0.00786	CcSEcCtD
Sevoflurane—Angiopathy—Furosemide—dilated cardiomyopathy	0.00396	0.00776	CcSEcCtD
Sevoflurane—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00395	0.00773	CcSEcCtD
Sevoflurane—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0039	0.00764	CcSEcCtD
Sevoflurane—Dysuria—Lisinopril—dilated cardiomyopathy	0.00383	0.0075	CcSEcCtD
Sevoflurane—Malnutrition—Furosemide—dilated cardiomyopathy	0.0038	0.00745	CcSEcCtD
Sevoflurane—Dizziness—Spironolactone—dilated cardiomyopathy	0.00377	0.00739	CcSEcCtD
Sevoflurane—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00373	0.00729	CcSEcCtD
Sevoflurane—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0037	0.00723	CcSEcCtD
Sevoflurane—Vomiting—Spironolactone—dilated cardiomyopathy	0.00363	0.0071	CcSEcCtD
Sevoflurane—Rash—Spironolactone—dilated cardiomyopathy	0.0036	0.00704	CcSEcCtD
Sevoflurane—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00359	0.00704	CcSEcCtD
Sevoflurane—Renal failure—Lisinopril—dilated cardiomyopathy	0.00359	0.00703	CcSEcCtD
Sevoflurane—Headache—Spironolactone—dilated cardiomyopathy	0.00357	0.007	CcSEcCtD
Sevoflurane—Jaundice—Lisinopril—dilated cardiomyopathy	0.00356	0.00697	CcSEcCtD
Sevoflurane—Agitation—Furosemide—dilated cardiomyopathy	0.0035	0.00684	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00345	0.00676	CcSEcCtD
Sevoflurane—Nausea—Spironolactone—dilated cardiomyopathy	0.00339	0.00664	CcSEcCtD
Sevoflurane—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00334	0.00653	CcSEcCtD
Sevoflurane—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00328	0.00642	CcSEcCtD
Sevoflurane—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00325	0.00637	CcSEcCtD
Sevoflurane—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00324	0.00634	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00322	0.0063	CcSEcCtD
Sevoflurane—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00321	0.00629	CcSEcCtD
Sevoflurane—Dry mouth—Furosemide—dilated cardiomyopathy	0.00317	0.0062	CcSEcCtD
Sevoflurane—Confusional state—Furosemide—dilated cardiomyopathy	0.00313	0.00613	CcSEcCtD
Sevoflurane—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0031	0.00608	CcSEcCtD
Sevoflurane—Shock—Furosemide—dilated cardiomyopathy	0.00305	0.00598	CcSEcCtD
Sevoflurane—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00304	0.00596	CcSEcCtD
Sevoflurane—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00304	0.00595	CcSEcCtD
Sevoflurane—Skin disorder—Furosemide—dilated cardiomyopathy	0.00302	0.0059	CcSEcCtD
Sevoflurane—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00297	0.00582	CcSEcCtD
Sevoflurane—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00295	0.00578	CcSEcCtD
Sevoflurane—Chills—Lisinopril—dilated cardiomyopathy	0.00294	0.00576	CcSEcCtD
Sevoflurane—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00293	0.00573	CcSEcCtD
Sevoflurane—Hypotension—Furosemide—dilated cardiomyopathy	0.0029	0.00568	CcSEcCtD
Sevoflurane—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00287	0.00562	CcSEcCtD
Sevoflurane—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00285	0.00559	CcSEcCtD
Sevoflurane—Tension—Lisinopril—dilated cardiomyopathy	0.0028	0.00548	CcSEcCtD
Sevoflurane—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0028	0.00547	CcSEcCtD
Sevoflurane—Nervousness—Lisinopril—dilated cardiomyopathy	0.00277	0.00543	CcSEcCtD
Sevoflurane—Somnolence—Furosemide—dilated cardiomyopathy	0.00276	0.0054	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00268	0.00525	CcSEcCtD
Sevoflurane—Pain—Furosemide—dilated cardiomyopathy	0.00265	0.0052	CcSEcCtD
Sevoflurane—Syncope—Lisinopril—dilated cardiomyopathy	0.00256	0.00501	CcSEcCtD
Sevoflurane—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00256	0.00501	CcSEcCtD
Sevoflurane—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00251	0.00491	CcSEcCtD
Sevoflurane—Cough—Lisinopril—dilated cardiomyopathy	0.00249	0.00488	CcSEcCtD
Sevoflurane—Urticaria—Furosemide—dilated cardiomyopathy	0.00247	0.00483	CcSEcCtD
Sevoflurane—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00245	0.0048	CcSEcCtD
Sevoflurane—Chest pain—Lisinopril—dilated cardiomyopathy	0.00243	0.00476	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00241	0.00472	CcSEcCtD
Sevoflurane—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00238	0.00465	CcSEcCtD
Sevoflurane—Confusional state—Lisinopril—dilated cardiomyopathy	0.00235	0.0046	CcSEcCtD
Sevoflurane—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00233	0.00456	CcSEcCtD
Sevoflurane—Oedema—Lisinopril—dilated cardiomyopathy	0.00233	0.00456	CcSEcCtD
Sevoflurane—Shock—Lisinopril—dilated cardiomyopathy	0.00229	0.00449	CcSEcCtD
Sevoflurane—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00229	0.00448	CcSEcCtD
Sevoflurane—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00228	0.00446	CcSEcCtD
Sevoflurane—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00227	0.00445	CcSEcCtD
Sevoflurane—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00226	0.00443	CcSEcCtD
Sevoflurane—Asthenia—Furosemide—dilated cardiomyopathy	0.00223	0.00436	CcSEcCtD
Sevoflurane—Pruritus—Furosemide—dilated cardiomyopathy	0.0022	0.0043	CcSEcCtD
Sevoflurane—Hypotension—Lisinopril—dilated cardiomyopathy	0.00218	0.00426	CcSEcCtD
Sevoflurane—Insomnia—Lisinopril—dilated cardiomyopathy	0.00211	0.00412	CcSEcCtD
Sevoflurane—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00208	0.00407	CcSEcCtD
Sevoflurane—Somnolence—Lisinopril—dilated cardiomyopathy	0.00207	0.00405	CcSEcCtD
Sevoflurane—Dizziness—Furosemide—dilated cardiomyopathy	0.00205	0.00402	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00201	0.00394	CcSEcCtD
Sevoflurane—Pain—Lisinopril—dilated cardiomyopathy	0.00199	0.0039	CcSEcCtD
Sevoflurane—Vomiting—Furosemide—dilated cardiomyopathy	0.00197	0.00386	CcSEcCtD
Sevoflurane—Rash—Furosemide—dilated cardiomyopathy	0.00196	0.00383	CcSEcCtD
Sevoflurane—Dermatitis—Furosemide—dilated cardiomyopathy	0.00196	0.00383	CcSEcCtD
Sevoflurane—KCNK3—heart—dilated cardiomyopathy	0.00195	0.0933	CbGeAlD
Sevoflurane—Headache—Furosemide—dilated cardiomyopathy	0.00194	0.00381	CcSEcCtD
Sevoflurane—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00192	0.00376	CcSEcCtD
Sevoflurane—Urticaria—Lisinopril—dilated cardiomyopathy	0.00185	0.00362	CcSEcCtD
Sevoflurane—Nausea—Furosemide—dilated cardiomyopathy	0.00184	0.00361	CcSEcCtD
Sevoflurane—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00184	0.0036	CcSEcCtD
Sevoflurane—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00172	0.00336	CcSEcCtD
Sevoflurane—Asthenia—Lisinopril—dilated cardiomyopathy	0.00167	0.00327	CcSEcCtD
Sevoflurane—ATP5D—cardiac ventricle—dilated cardiomyopathy	0.00166	0.0794	CbGeAlD
Sevoflurane—Pruritus—Lisinopril—dilated cardiomyopathy	0.00165	0.00323	CcSEcCtD
Sevoflurane—ATP2C1—cardiac ventricle—dilated cardiomyopathy	0.00164	0.0784	CbGeAlD
Sevoflurane—ATP5D—myocardium—dilated cardiomyopathy	0.00156	0.0747	CbGeAlD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00156	0.00333	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—ACTN2—dilated cardiomyopathy	0.00155	0.00332	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.00154	0.0033	CbGpPWpGaD
Sevoflurane—Dizziness—Lisinopril—dilated cardiomyopathy	0.00154	0.00302	CcSEcCtD
Sevoflurane—ATP2C1—myocardium—dilated cardiomyopathy	0.00154	0.0737	CbGeAlD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00154	0.00328	CbGpPWpGaD
Sevoflurane—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00153	0.00328	CbGpPWpGaD
Sevoflurane—GABRA4—myocardium—dilated cardiomyopathy	0.00152	0.0728	CbGeAlD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—TNF—dilated cardiomyopathy	0.0015	0.00321	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0015	0.00319	CbGpPWpGaD
Sevoflurane—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00149	0.00319	CbGpPWpGaD
Sevoflurane—Vomiting—Lisinopril—dilated cardiomyopathy	0.00148	0.0029	CcSEcCtD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00147	0.00314	CbGpPWpGaD
Sevoflurane—Rash—Lisinopril—dilated cardiomyopathy	0.00147	0.00288	CcSEcCtD
Sevoflurane—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00147	0.00287	CcSEcCtD
Sevoflurane—Headache—Lisinopril—dilated cardiomyopathy	0.00146	0.00286	CcSEcCtD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00141	0.003	CbGpPWpGaD
Sevoflurane—Nausea—Lisinopril—dilated cardiomyopathy	0.00138	0.00271	CcSEcCtD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00137	0.00292	CbGpPWpGaD
Sevoflurane—ND1—heart—dilated cardiomyopathy	0.00135	0.0647	CbGeAlD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00134	0.00286	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00134	0.00286	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00134	0.00285	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00132	0.00282	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00132	0.00282	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00132	0.00281	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00131	0.0028	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00129	0.00275	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00128	0.00273	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00128	0.00272	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00126	0.00269	CbGpPWpGaD
Sevoflurane—ATP2C1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00126	0.00268	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00124	0.00266	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00123	0.00262	CbGpPWpGaD
Sevoflurane—GABRE—cardiac ventricle—dilated cardiomyopathy	0.00122	0.0587	CbGeAlD
Sevoflurane—GRIA1—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00119	0.00255	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00119	0.00255	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00118	0.00252	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00114	0.00243	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00112	0.0024	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00112	0.0024	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ANKRD1—dilated cardiomyopathy	0.0011	0.00236	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ANKRD1—dilated cardiomyopathy	0.0011	0.00236	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00109	0.00233	CbGpPWpGaD
Sevoflurane—ATP5D—heart—dilated cardiomyopathy	0.00109	0.0521	CbGeAlD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00109	0.00232	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00108	0.0023	CbGpPWpGaD
Sevoflurane—ATP2C1—heart—dilated cardiomyopathy	0.00107	0.0515	CbGeAlD
Sevoflurane—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00107	0.00229	CbGpPWpGaD
Sevoflurane—GLRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00107	0.00228	CbGpPWpGaD
Sevoflurane—GABRA4—heart—dilated cardiomyopathy	0.00106	0.0508	CbGeAlD
Sevoflurane—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00105	0.00225	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00105	0.00224	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00105	0.00224	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TAZ—dilated cardiomyopathy	0.00104	0.00221	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TAZ—dilated cardiomyopathy	0.00104	0.00221	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00103	0.00219	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00103	0.00219	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00101	0.00216	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.001	0.00214	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000985	0.0021	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000964	0.00206	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—SDHA—dilated cardiomyopathy	0.000938	0.002	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—SDHA—dilated cardiomyopathy	0.000938	0.002	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000938	0.002	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000938	0.002	CbGpPWpGaD
Sevoflurane—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000932	0.00199	CbGpPWpGaD
Sevoflurane—ATP5D—cardiac atrium—dilated cardiomyopathy	0.00093	0.0446	CbGeAlD
Sevoflurane—ATP2C1—cardiac atrium—dilated cardiomyopathy	0.000918	0.044	CbGeAlD
Sevoflurane—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000898	0.00192	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—RAF1—dilated cardiomyopathy	0.000874	0.00187	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000872	0.00186	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000861	0.00184	CbGpPWpGaD
Sevoflurane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000833	0.00178	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00081	0.00173	CbGpPWpGaD
Sevoflurane—GABRE—heart—dilated cardiomyopathy	0.000803	0.0385	CbGeAlD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000794	0.0017	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000792	0.00169	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000782	0.00167	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000772	0.00165	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000772	0.00165	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000761	0.00162	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000761	0.00162	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000753	0.00161	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00074	0.00158	CbGpPWpGaD
Sevoflurane—ALB—heart—dilated cardiomyopathy	0.000732	0.0351	CbGeAlD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000731	0.00156	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00072	0.00154	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00072	0.00154	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000718	0.00153	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—RAF1—dilated cardiomyopathy	0.000712	0.00152	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000711	0.00152	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000711	0.00152	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000707	0.00151	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000691	0.00148	CbGpPWpGaD
Sevoflurane—GABRE—cardiac atrium—dilated cardiomyopathy	0.000687	0.0329	CbGeAlD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000685	0.00146	CbGpPWpGaD
Sevoflurane—GABRB3—heart—dilated cardiomyopathy	0.000681	0.0326	CbGeAlD
Sevoflurane—KCNK2—Neuronal System—RAF1—dilated cardiomyopathy	0.000681	0.00145	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000669	0.00143	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000668	0.00143	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—RAF1—dilated cardiomyopathy	0.000662	0.00141	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—RAF1—dilated cardiomyopathy	0.000662	0.00141	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000661	0.00141	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00065	0.00139	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00065	0.00139	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000649	0.00139	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000647	0.00138	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000637	0.00136	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000631	0.00135	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000631	0.00135	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000626	0.00134	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000622	0.00133	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00062	0.00132	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00062	0.00132	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000618	0.00132	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000614	0.00131	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000612	0.00131	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000611	0.0013	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000609	0.0013	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000609	0.0013	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000609	0.0013	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000605	0.00129	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000605	0.00129	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000604	0.00129	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000594	0.00127	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000594	0.00127	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000594	0.00127	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000587	0.00125	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000585	0.00125	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000584	0.00125	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000584	0.00125	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000576	0.00123	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000566	0.00121	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000563	0.0012	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000553	0.00118	CbGpPWpGaD
Sevoflurane—GABRQ—Ion channel transport—RAF1—dilated cardiomyopathy	0.000546	0.00117	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000535	0.00114	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000534	0.00114	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00052	0.00111	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00052	0.00111	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000506	0.00108	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000505	0.00108	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000498	0.00106	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000488	0.00104	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000486	0.00104	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000483	0.00103	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000471	0.00101	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000467	0.000996	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000465	0.000994	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000465	0.000992	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000464	0.000991	CbGpPWpGaD
Sevoflurane—CYP2B6—heart—dilated cardiomyopathy	0.000462	0.0221	CbGeAlD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000462	0.000986	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000451	0.000964	CbGpPWpGaD
Sevoflurane—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00045	0.000961	CbGpPWpGaD
Sevoflurane—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000443	0.000946	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000437	0.000933	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000426	0.000909	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000424	0.000906	CbGpPWpGaD
Sevoflurane—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000419	0.000895	CbGpPWpGaD
Sevoflurane—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000414	0.000884	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000413	0.000883	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000406	0.000867	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000399	0.000852	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000396	0.000846	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000389	0.000831	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000388	0.000828	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00038	0.000812	CbGpPWpGaD
Sevoflurane—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000379	0.000809	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000374	0.0008	CbGpPWpGaD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000371	0.000793	CbGpPWpGaD
Sevoflurane—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000368	0.000786	CbGpPWpGaD
Sevoflurane—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000361	0.000771	CbGpPWpGaD
Sevoflurane—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000355	0.000758	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000354	0.000757	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—RAF1—dilated cardiomyopathy	0.000354	0.000755	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000353	0.000754	CbGpPWpGaD
Sevoflurane—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000353	0.000753	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00035	0.000747	CbGpPWpGaD
Sevoflurane—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000346	0.00074	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00034	0.000727	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00032	0.000683	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000311	0.000664	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000306	0.000654	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000306	0.000653	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000305	0.000652	CbGpPWpGaD
Sevoflurane—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000303	0.000646	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0003	0.000641	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000298	0.000636	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000297	0.000635	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000297	0.000635	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000296	0.000632	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000293	0.000625	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000291	0.000622	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000287	0.000613	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000285	0.000609	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000278	0.000594	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000277	0.00059	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000271	0.00058	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000268	0.000572	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.00026	0.000556	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000256	0.000546	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GPX1—dilated cardiomyopathy	0.000255	0.000544	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GPX1—dilated cardiomyopathy	0.000255	0.000544	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000252	0.000537	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CD36—dilated cardiomyopathy	0.000248	0.00053	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CD36—dilated cardiomyopathy	0.000248	0.00053	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000245	0.000523	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000239	0.00051	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000238	0.000509	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000234	0.000499	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000234	0.000499	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000232	0.000496	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00023	0.000491	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000228	0.000488	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000224	0.000479	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000224	0.000479	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AGT—dilated cardiomyopathy	0.000223	0.000477	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AGT—dilated cardiomyopathy	0.000223	0.000477	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.00022	0.00047	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000216	0.000462	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000204	0.000435	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000204	0.000435	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000203	0.000434	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000201	0.000429	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000199	0.000425	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000196	0.000418	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00019	0.000406	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000189	0.000404	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000184	0.000394	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000171	0.000365	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000157	0.000334	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000154	0.000329	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000146	0.000312	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000144	0.000308	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000135	0.000289	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000132	0.000281	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	0.000131	0.000279	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000128	0.000273	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000126	0.000268	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000124	0.000264	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000123	0.000262	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000121	0.000257	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CD36—dilated cardiomyopathy	0.000112	0.000238	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000108	0.000232	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000105	0.000225	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAC1—dilated cardiomyopathy	0.000105	0.000224	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000104	0.000223	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000102	0.000218	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000102	0.000217	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.23e-05	0.000197	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.14e-05	0.000195	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAF1—dilated cardiomyopathy	6.97e-05	0.000149	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	6.84e-05	0.000146	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	6.66e-05	0.000142	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.03e-05	0.000129	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	5.99e-05	0.000128	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	5.51e-05	0.000118	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	5.4e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	5.37e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	5.26e-05	0.000112	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	4.84e-05	0.000103	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	4.74e-05	0.000101	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.64e-05	9.91e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CD36—dilated cardiomyopathy	4.52e-05	9.65e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AGT—dilated cardiomyopathy	4.07e-05	8.69e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.51e-05	5.35e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.44e-05	5.21e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.2e-05	4.69e-05	CbGpPWpGaD
